Stock PHR PHARMENA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Pharmena S.A.

Equities

PHR

PLPHRMN00011

Market Closed - Warsaw S.E.
Other stock markets
 16:55:44 17/05/2024 BST 		5-day change 1st Jan Change
6.44 PLN +1.26% Intraday chart for Pharmena S.A. -0.92% -9.30%
02-29 Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Grupo AC MARCA SL entered into an agreement to acquire Dermena from Pharmena S.A.
CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Pharmena S.A. announced that it has received PLN 15.0858 million in funding from Pelion S.A.
CI
Pharmena S.A. announced that it expects to receive funding from Pelion S.A.
CI
Pharmena S.A. announced that it expects to receive PLN 0.299998 million in funding
CI
Cortria Corporation announced that it has received $0.2 million in funding from Pharmena S.A.
CI
Cortria Corporation announced that it has received $0.3 million in funding from Pharmena S.A.
CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.
CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. sold 6.91% stake in Pharmena Spolka Akcyjna.
CI
Pelion S.A. acquired an additional 6.91% stake in Pharmena Spolka Akcyjna.
CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHR Stock
  4. News Pharmena S.A.